The uptake rates of influenza vaccine in pregnant women in the Nelson region of New Zealand
View Article PDF
Pregnant women were particularly vulnerable during the 2009 H1N1 pandemic. H1N1 was the leading cause of indirect maternal death in New Zealand in 2009.1 Given the safety of influenza vaccination in pregnancy2,3 and the risks of infection,4–7 the RANZCOG advises recommendation of the influenza vaccine to all pregnant women regardless of gestation; it is also free of charge to this group.Two years since the H1N1 pandemic, a survey of pregnant women was carried out in order to determine whether the events of that year had impacted on behaviours with regards to vaccination of pregnant women against influenza.Pregnant women who attended antenatal clinic or delivery suite at Nelson hospital during October and November 2011 were surveyed on their influenza vaccination status. They were asked whether they had been recommended the influenza vaccination and their reasons for not being vaccinated.110 of 131 eligible women (84%) participated in the survey. Only 12 (11%) had received the influenza vaccine in 2011. Twenty-two women (20%) had been recommended the vaccine, however many of these were for reasons other than pregnancy. Disappointingly, five women had been advised against the influenza vaccine by a health professional. The main reason stated for not being vaccinated was an unawareness of the recommendation that pregnant women should be vaccinated against influenza.Despite guidelines recommending influenza vaccination for all pregnant women, uptake was low in this local population. Health practitioners caring for pregnant women should be educated on the benefits of influenza vaccination in pregnant women and advocate its use. This may improve uptake rates in New Zealand in this high-risk group. Sylvia Ross1; Judy Ormandy2; Bia Jungji Kim1 Trainee Intern, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand Obstetrics & Gynaecology Senior Registrar, Nelson Hospital, Nelson, New Zealand
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
PMMRC. 2011. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2009. Wellington: Health Quality & Safety Commission 2011. Available from: URL: http://www.pmmrc.health.govt.nz/moh.nsf/Files/pmmrcfiles2011/$file/pmmrc-5th-report-2009.pdf Accessed 27 September 2011Safety of influenza vaccination during pregnancy. Tamma PD, Ault KA, del Rio C, Steinhoff MC, et al. Am J Obstet Gynecol. 2009;201(6):547-528.Moro PL, Broder K, Zheteyeva Y, Walton K, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol. 2011;204(2):146.e1-7.ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;18;340:c1279.Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;14;342:d3214.Zaman K, Roy E, Arifeen SE, Rahman M, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;9;359(15):1555-64.Benowitz I, Esposito DB, Gracey KD, Shapiro ED, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;15;51(12):1355-61
For the PDF of this article,
contact nzmj@nzma.org.nz
The uptake rates of influenza vaccine in pregnant women in the Nelson region of New Zealand
View Article PDF
Pregnant women were particularly vulnerable during the 2009 H1N1 pandemic. H1N1 was the leading cause of indirect maternal death in New Zealand in 2009.1 Given the safety of influenza vaccination in pregnancy2,3 and the risks of infection,4–7 the RANZCOG advises recommendation of the influenza vaccine to all pregnant women regardless of gestation; it is also free of charge to this group.Two years since the H1N1 pandemic, a survey of pregnant women was carried out in order to determine whether the events of that year had impacted on behaviours with regards to vaccination of pregnant women against influenza.Pregnant women who attended antenatal clinic or delivery suite at Nelson hospital during October and November 2011 were surveyed on their influenza vaccination status. They were asked whether they had been recommended the influenza vaccination and their reasons for not being vaccinated.110 of 131 eligible women (84%) participated in the survey. Only 12 (11%) had received the influenza vaccine in 2011. Twenty-two women (20%) had been recommended the vaccine, however many of these were for reasons other than pregnancy. Disappointingly, five women had been advised against the influenza vaccine by a health professional. The main reason stated for not being vaccinated was an unawareness of the recommendation that pregnant women should be vaccinated against influenza.Despite guidelines recommending influenza vaccination for all pregnant women, uptake was low in this local population. Health practitioners caring for pregnant women should be educated on the benefits of influenza vaccination in pregnant women and advocate its use. This may improve uptake rates in New Zealand in this high-risk group. Sylvia Ross1; Judy Ormandy2; Bia Jungji Kim1 Trainee Intern, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand Obstetrics & Gynaecology Senior Registrar, Nelson Hospital, Nelson, New Zealand
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
PMMRC. 2011. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2009. Wellington: Health Quality & Safety Commission 2011. Available from: URL: http://www.pmmrc.health.govt.nz/moh.nsf/Files/pmmrcfiles2011/$file/pmmrc-5th-report-2009.pdf Accessed 27 September 2011Safety of influenza vaccination during pregnancy. Tamma PD, Ault KA, del Rio C, Steinhoff MC, et al. Am J Obstet Gynecol. 2009;201(6):547-528.Moro PL, Broder K, Zheteyeva Y, Walton K, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol. 2011;204(2):146.e1-7.ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;18;340:c1279.Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;14;342:d3214.Zaman K, Roy E, Arifeen SE, Rahman M, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;9;359(15):1555-64.Benowitz I, Esposito DB, Gracey KD, Shapiro ED, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;15;51(12):1355-61
For the PDF of this article,
contact nzmj@nzma.org.nz
The uptake rates of influenza vaccine in pregnant women in the Nelson region of New Zealand
View Article PDF
Pregnant women were particularly vulnerable during the 2009 H1N1 pandemic. H1N1 was the leading cause of indirect maternal death in New Zealand in 2009.1 Given the safety of influenza vaccination in pregnancy2,3 and the risks of infection,4–7 the RANZCOG advises recommendation of the influenza vaccine to all pregnant women regardless of gestation; it is also free of charge to this group.Two years since the H1N1 pandemic, a survey of pregnant women was carried out in order to determine whether the events of that year had impacted on behaviours with regards to vaccination of pregnant women against influenza.Pregnant women who attended antenatal clinic or delivery suite at Nelson hospital during October and November 2011 were surveyed on their influenza vaccination status. They were asked whether they had been recommended the influenza vaccination and their reasons for not being vaccinated.110 of 131 eligible women (84%) participated in the survey. Only 12 (11%) had received the influenza vaccine in 2011. Twenty-two women (20%) had been recommended the vaccine, however many of these were for reasons other than pregnancy. Disappointingly, five women had been advised against the influenza vaccine by a health professional. The main reason stated for not being vaccinated was an unawareness of the recommendation that pregnant women should be vaccinated against influenza.Despite guidelines recommending influenza vaccination for all pregnant women, uptake was low in this local population. Health practitioners caring for pregnant women should be educated on the benefits of influenza vaccination in pregnant women and advocate its use. This may improve uptake rates in New Zealand in this high-risk group. Sylvia Ross1; Judy Ormandy2; Bia Jungji Kim1 Trainee Intern, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand Obstetrics & Gynaecology Senior Registrar, Nelson Hospital, Nelson, New Zealand
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
PMMRC. 2011. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2009. Wellington: Health Quality & Safety Commission 2011. Available from: URL: http://www.pmmrc.health.govt.nz/moh.nsf/Files/pmmrcfiles2011/$file/pmmrc-5th-report-2009.pdf Accessed 27 September 2011Safety of influenza vaccination during pregnancy. Tamma PD, Ault KA, del Rio C, Steinhoff MC, et al. Am J Obstet Gynecol. 2009;201(6):547-528.Moro PL, Broder K, Zheteyeva Y, Walton K, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol. 2011;204(2):146.e1-7.ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;18;340:c1279.Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;14;342:d3214.Zaman K, Roy E, Arifeen SE, Rahman M, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;9;359(15):1555-64.Benowitz I, Esposito DB, Gracey KD, Shapiro ED, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;15;51(12):1355-61
Contact diana@nzma.org.nz
for the PDF of this article
The uptake rates of influenza vaccine in pregnant women in the Nelson region of New Zealand
View Article PDF
Pregnant women were particularly vulnerable during the 2009 H1N1 pandemic. H1N1 was the leading cause of indirect maternal death in New Zealand in 2009.1 Given the safety of influenza vaccination in pregnancy2,3 and the risks of infection,4–7 the RANZCOG advises recommendation of the influenza vaccine to all pregnant women regardless of gestation; it is also free of charge to this group.Two years since the H1N1 pandemic, a survey of pregnant women was carried out in order to determine whether the events of that year had impacted on behaviours with regards to vaccination of pregnant women against influenza.Pregnant women who attended antenatal clinic or delivery suite at Nelson hospital during October and November 2011 were surveyed on their influenza vaccination status. They were asked whether they had been recommended the influenza vaccination and their reasons for not being vaccinated.110 of 131 eligible women (84%) participated in the survey. Only 12 (11%) had received the influenza vaccine in 2011. Twenty-two women (20%) had been recommended the vaccine, however many of these were for reasons other than pregnancy. Disappointingly, five women had been advised against the influenza vaccine by a health professional. The main reason stated for not being vaccinated was an unawareness of the recommendation that pregnant women should be vaccinated against influenza.Despite guidelines recommending influenza vaccination for all pregnant women, uptake was low in this local population. Health practitioners caring for pregnant women should be educated on the benefits of influenza vaccination in pregnant women and advocate its use. This may improve uptake rates in New Zealand in this high-risk group. Sylvia Ross1; Judy Ormandy2; Bia Jungji Kim1 Trainee Intern, Christchurch School of Medicine, University of Otago, Christchurch, New Zealand Obstetrics & Gynaecology Senior Registrar, Nelson Hospital, Nelson, New Zealand
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
PMMRC. 2011. Fifth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2009. Wellington: Health Quality & Safety Commission 2011. Available from: URL: http://www.pmmrc.health.govt.nz/moh.nsf/Files/pmmrcfiles2011/$file/pmmrc-5th-report-2009.pdf Accessed 27 September 2011Safety of influenza vaccination during pregnancy. Tamma PD, Ault KA, del Rio C, Steinhoff MC, et al. Am J Obstet Gynecol. 2009;201(6):547-528.Moro PL, Broder K, Zheteyeva Y, Walton K, et al. Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009. Am J Obstet Gynecol. 2011;204(2):146.e1-7.ANZIC Influenza Investigators and Australasian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study. BMJ. 2010;18;340:c1279.Pierce M, Kurinczuk JJ, Spark P, Brocklehurst P, et al. Perinatal outcomes after maternal 2009/H1N1 infection: national cohort study. BMJ. 2011;14;342:d3214.Zaman K, Roy E, Arifeen SE, Rahman M, et al. Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med. 2008;9;359(15):1555-64.Benowitz I, Esposito DB, Gracey KD, Shapiro ED, et al. Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants. Clin Infect Dis. 2010;15;51(12):1355-61
Contact diana@nzma.org.nz
for the PDF of this article
The uptake rates of influenza vaccine in pregnant women in the Nelson region of New Zealand
Subscriber Content
The full contents of this pages only available to subscribers.
Login, subscribe or email nzmj@nzma.org.nz to purchase this article.
